Clinical Trial: Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
Brief Summary: The purpose of this study is to further characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic-intramyocellular lipids in patients with growth hormone deficiency (GHD).
Detailed Summary:
Sponsor: University of Aarhus
Current Primary Outcome: insulin sensitivity [ Time Frame: before and after 3 months treatment with growth hormone ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- substrate metabolism [ Time Frame: before and after 3 months of growth hormone treatment ]
- intrahepatic lipid content [ Time Frame: before and after 3 months of growth hormone treatment ]
- intramyocellular lipid content [ Time Frame: before and after 3 months of growth hormone treatment ]
Original Secondary Outcome: Same as current
Information By: University of Aarhus
Dates:
Date Received: February 19, 2008
Date Started: March 2008
Date Completion:
Last Updated: October 21, 2009
Last Verified: October 2009
